← Leaderboards
Kevin O'Connor
Univ Of Massachusetts Med Sch Worcester
$152,605
Attributed
$152,605
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.6K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$152,605 · 1
By mechanism
F30$152,605 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Michelle Alice Kelliher$16,226,746
- Shaoguang Li$10,655,005
- Hong Zhang$5,730,313
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesAcute T Cell LeukemiaGene Expression ProfileCalcineurinCell CycleCell PhysiologyBeta CateninAcute T-Cell Lymphoblastic Leukemia CellCell SeparationCell SurfaceChemoresistanceChemotherapyChildChildhood Acute Lymphocytic LeukemiaChildhood Precursor T Lymphoblastic LeukemiaDatabasesCellsDifferential ExpressionDisease RemissionExhibitsFailureFoundationsFrequenciesGenetically Engineered Mouse
Grant awards (4)
Targeting dormant leukemia-initiating cells in T-cell acute lymphoblastic leukemia$50,649
F30 · FY2024 · CA · contact PI
Targeting dormant leukemia-initiating cells in T-cell acute lymphoblastic leukemia$34,852
F30 · FY2023 · CA · contact PI
Targeting dormant leukemia-initiating cells in T-cell acute lymphoblastic leukemia$33,910
F30 · FY2022 · CA · contact PI
Targeting dormant leukemia-initiating cells in T-cell acute lymphoblastic leukemia$33,194
F30 · FY2021 · CA · contact PI